• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐药性突变改变与抑制剂结合的HIV-1蛋白酶的动力学。

Drug Resistance Mutations Alter Dynamics of Inhibitor-Bound HIV-1 Protease.

作者信息

Cai Yufeng, Myint Wazo, Paulsen Janet L, Schiffer Celia A, Ishima Rieko, Kurt Yilmaz Nese

机构信息

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School , Worcester, Massachusetts 01605, United States.

Department of Structural Biology, School of Medicine, University of Pittsburgh Biomedical Science Tower 3 , 3501 Fifth Avenue, Pittsburgh, Pennsylvania 15260, United States.

出版信息

J Chem Theory Comput. 2014 Aug 12;10(8):3438-3448. doi: 10.1021/ct4010454. Epub 2014 Jun 12.

DOI:10.1021/ct4010454
PMID:25136270
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4132871/
Abstract

Under the selective pressure of therapy, HIV-1 protease mutants resistant to inhibitors evolve to confer drug resistance. Such mutations can impact both the dynamics and structures of the bound and unbound forms of the enzyme. Flap+ is a multidrug-resistant variant of HIV-1 protease with a combination of primary and secondary resistance mutations (L10I, G48V, I54V, V82A) and a strikingly altered thermodynamic profile for darunavir (DRV) binding relative to the wild-type protease. We elucidated the impact of these mutations on protein dynamics in the DRV-bound state using molecular dynamics simulations and NMR relaxation experiments. Both methods concur in that the conformational ensemble and dynamics of protease are impacted by the drug resistance mutations in Flap+ variant. Surprisingly this change in ensemble dynamics is different from that observed in the unliganded form of the same variant (Cai, Y. et al. , , 3452-3462). Our comparative analysis of both inhibitor-free and bound states presents a comprehensive picture of the altered dynamics in drug-resistant mutant HIV-1 protease and underlies the importance of incorporating dynamic analysis of the whole system, including the unliganded state, into revealing drug resistance mechanisms.

摘要

在治疗的选择压力下,对抑制剂耐药的HIV-1蛋白酶突变体不断进化以产生耐药性。此类突变会影响该酶结合态与游离态的动力学和结构。Flap+是HIV-1蛋白酶的一种多药耐药变体,具有一级和二级耐药突变(L10I、G48V、I54V、V82A)的组合,并且相对于野生型蛋白酶,其对达芦那韦(DRV)结合的热力学概况有显著改变。我们使用分子动力学模拟和核磁共振弛豫实验阐明了这些突变对处于DRV结合状态的蛋白质动力学的影响。两种方法均一致认为,蛋白酶的构象集合和动力学受到Flap+变体中耐药突变的影响。令人惊讶的是,这种集合动力学的变化与在同一变体的无配体形式中观察到的不同(Cai, Y.等人,,3452 - 3462)。我们对无抑制剂状态和结合状态的比较分析呈现了耐药突变型HIV-1蛋白酶中动力学改变的全面情况,并突出了将包括无配体状态在内的整个系统的动力学分析纳入揭示耐药机制的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e640/4132871/39e2a77068f1/ct-2013-010454_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e640/4132871/48649dad208f/ct-2013-010454_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e640/4132871/37dde7508c49/ct-2013-010454_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e640/4132871/2132c096c38d/ct-2013-010454_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e640/4132871/22a47ce81eb5/ct-2013-010454_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e640/4132871/c7b7b8b67820/ct-2013-010454_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e640/4132871/67f21a3f86b0/ct-2013-010454_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e640/4132871/39e2a77068f1/ct-2013-010454_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e640/4132871/48649dad208f/ct-2013-010454_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e640/4132871/37dde7508c49/ct-2013-010454_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e640/4132871/2132c096c38d/ct-2013-010454_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e640/4132871/22a47ce81eb5/ct-2013-010454_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e640/4132871/c7b7b8b67820/ct-2013-010454_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e640/4132871/67f21a3f86b0/ct-2013-010454_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e640/4132871/39e2a77068f1/ct-2013-010454_0005.jpg

相似文献

1
Drug Resistance Mutations Alter Dynamics of Inhibitor-Bound HIV-1 Protease.耐药性突变改变与抑制剂结合的HIV-1蛋白酶的动力学。
J Chem Theory Comput. 2014 Aug 12;10(8):3438-3448. doi: 10.1021/ct4010454. Epub 2014 Jun 12.
2
Differential Flap Dynamics in Wild-type and a Drug Resistant Variant of HIV-1 Protease Revealed by Molecular Dynamics and NMR Relaxation.分子动力学和核磁共振弛豫揭示的野生型和HIV-1蛋白酶耐药变体中的差异瓣动态
J Chem Theory Comput. 2012 Oct 9;8(10):3452-3462. doi: 10.1021/ct300076y. Epub 2012 Apr 17.
3
Decomposing the energetic impact of drug resistant mutations in HIV-1 protease on binding DRV.剖析HIV-1蛋白酶中耐药性突变对结合地瑞那韦的能量影响。
J Chem Theory Comput. 2010 Apr 13;6(4):1358-1368. doi: 10.1021/ct9004678.
4
Structural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap Dynamics.对合理选择的多药耐药HIV-1蛋白酶的结构研究揭示了远端突变对瓣片动力学的协同作用。
PLoS One. 2016 Dec 16;11(12):e0168616. doi: 10.1371/journal.pone.0168616. eCollection 2016.
5
Effect of flap mutations on structure of HIV-1 protease and inhibition by saquinavir and darunavir.瓣突变对HIV-1蛋白酶结构以及沙奎那韦和达芦那韦抑制作用的影响。
J Mol Biol. 2008 Aug 1;381(1):102-15. doi: 10.1016/j.jmb.2008.05.062. Epub 2008 Jul 1.
6
Effects of drug-resistant mutations on the dynamic properties of HIV-1 protease and inhibition by Amprenavir and Darunavir.耐药性突变对HIV-1蛋白酶动力学特性的影响以及安普那韦和达芦那韦的抑制作用。
Sci Rep. 2015 May 27;5:10517. doi: 10.1038/srep10517.
7
Systematic molecular dynamics, MM-PBSA, and ab initio approaches to the saquinavir resistance mechanism in HIV-1 PR due to 11 double and multiple mutations.系统分子动力学、MM-PBSA 和从头计算方法研究 11 种双重和多种突变导致的 HIV-1 PR 中沙奎那韦耐药机制。
J Phys Chem B. 2014 Aug 14;118(32):9538-52. doi: 10.1021/jp502687q. Epub 2014 Jul 31.
8
Multi-drug resistance profile of PR20 HIV-1 protease is attributed to distorted conformational and drug binding landscape: molecular dynamics insights.PR20 HIV-1 蛋白酶的多药耐药谱归因于扭曲的构象和药物结合景观:分子动力学见解。
J Biomol Struct Dyn. 2016;34(1):135-51. doi: 10.1080/07391102.2015.1018326. Epub 2015 Mar 27.
9
Cooperative effects of drug-resistance mutations in the flap region of HIV-1 protease.HIV-1 蛋白酶瓣区耐药突变的协同作用。
ACS Chem Biol. 2013 Mar 15;8(3):513-8. doi: 10.1021/cb3006193. Epub 2012 Dec 27.
10
A synergy of activity, stability, and inhibitor-interaction of HIV-1 protease mutants evolved under drug-pressure.在药物压力下进化的 HIV-1 蛋白酶突变体的活性、稳定性和抑制剂相互作用的协同作用。
Protein Sci. 2021 Mar;30(3):571-582. doi: 10.1002/pro.4013. Epub 2020 Dec 22.

引用本文的文献

1
Dynamic Allostery: Evolution's Double-Edged Sword in Protein Function and Disease.动态变构:蛋白质功能与疾病中进化的双刃剑
J Mol Biol. 2025 Apr 24:169175. doi: 10.1016/j.jmb.2025.169175.
2
Viral proteases: Structure, mechanism and inhibition.病毒蛋白酶:结构、机制与抑制。
Enzymes. 2021;50:301-333. doi: 10.1016/bs.enz.2021.09.004. Epub 2021 Nov 17.
3
Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond.直接作用抗病毒药物及其他药物的耐药性规避药物设计策略。

本文引用的文献

1
Water networks contribute to enthalpy/entropy compensation in protein-ligand binding.水网络有助于蛋白质-配体结合中的焓/熵补偿。
J Am Chem Soc. 2013 Oct 16;135(41):15579-84. doi: 10.1021/ja4075776. Epub 2013 Oct 3.
2
Substrate envelope-designed potent HIV-1 protease inhibitors to avoid drug resistance.基于底物包膜设计的强效HIV-1蛋白酶抑制剂以避免耐药性。
Chem Biol. 2013 Sep 19;20(9):1116-24. doi: 10.1016/j.chembiol.2013.07.014. Epub 2013 Sep 5.
3
Elucidating a relationship between conformational sampling and drug resistance in HIV-1 protease.
Chem Rev. 2021 Mar 24;121(6):3238-3270. doi: 10.1021/acs.chemrev.0c00648. Epub 2021 Jan 7.
4
A synergy of activity, stability, and inhibitor-interaction of HIV-1 protease mutants evolved under drug-pressure.在药物压力下进化的 HIV-1 蛋白酶突变体的活性、稳定性和抑制剂相互作用的协同作用。
Protein Sci. 2021 Mar;30(3):571-582. doi: 10.1002/pro.4013. Epub 2020 Dec 22.
5
Darunavir-Resistant HIV-1 Protease Constructs Uphold a Conformational Selection Hypothesis for Drug Resistance.达芦那韦耐药 HIV-1 蛋白酶构建体支持耐药性的构象选择假说。
Viruses. 2020 Nov 8;12(11):1275. doi: 10.3390/v12111275.
6
Mutations in penicillin-binding protein 2 from cephalosporin-resistant hinder ceftriaxone acylation by restricting protein dynamics.头孢菌素耐药的青霉素结合蛋白 2 突变阻碍了头孢曲松的酰化作用,限制了蛋白质的动力学。
J Biol Chem. 2020 May 22;295(21):7529-7543. doi: 10.1074/jbc.RA120.012617. Epub 2020 Apr 6.
7
NMR and MD studies combined to elucidate inhibitor and water interactions of HIV-1 protease and their modulations with resistance mutations.NMR 和 MD 研究联合阐明了 HIV-1 蛋白酶抑制剂和水的相互作用及其与耐药突变的调节。
J Biomol NMR. 2019 Jul;73(6-7):365-374. doi: 10.1007/s10858-019-00260-6. Epub 2019 Jun 26.
8
Characterizing early drug resistance-related events using geometric ensembles from HIV protease dynamics.利用 HIV 蛋白酶动力学的几何系综来描述早期耐药相关事件。
Sci Rep. 2018 Dec 18;8(1):17938. doi: 10.1038/s41598-018-36041-8.
9
An NMR strategy to detect conformational differences in a protein complexed with highly analogous inhibitors in solution.一种 NMR 策略,用于检测溶液中与高度类似抑制剂结合的蛋白质复合物的构象差异。
Methods. 2018 Sep 15;148:9-18. doi: 10.1016/j.ymeth.2018.04.005. Epub 2018 Apr 12.
10
Hydration Structure and Dynamics of Inhibitor-Bound HIV-1 Protease.抑制剂结合的 HIV-1 蛋白酶的水合结构和动力学。
J Chem Theory Comput. 2018 May 8;14(5):2784-2796. doi: 10.1021/acs.jctc.8b00097. Epub 2018 Apr 18.
阐明 HIV-1 蛋白酶构象采样与耐药性之间的关系。
Biochemistry. 2013 May 14;52(19):3278-88. doi: 10.1021/bi400109d. Epub 2013 May 1.
4
Cooperative effects of drug-resistance mutations in the flap region of HIV-1 protease.HIV-1 蛋白酶瓣区耐药突变的协同作用。
ACS Chem Biol. 2013 Mar 15;8(3):513-8. doi: 10.1021/cb3006193. Epub 2012 Dec 27.
5
Entropy-enthalpy transduction caused by conformational shifts can obscure the forces driving protein-ligand binding.构象变化引起的熵-焓传递可能会掩盖驱动蛋白质-配体结合的力。
Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):20006-11. doi: 10.1073/pnas.1213180109. Epub 2012 Nov 13.
6
Differential Flap Dynamics in Wild-type and a Drug Resistant Variant of HIV-1 Protease Revealed by Molecular Dynamics and NMR Relaxation.分子动力学和核磁共振弛豫揭示的野生型和HIV-1蛋白酶耐药变体中的差异瓣动态
J Chem Theory Comput. 2012 Oct 9;8(10):3452-3462. doi: 10.1021/ct300076y. Epub 2012 Apr 17.
7
Correlating conformational shift induction with altered inhibitor potency in a multidrug resistant HIV-1 protease variant.与多药耐药 HIV-1 蛋白酶变体中抑制剂效力改变相关的构象变化诱导。
Biochemistry. 2012 Oct 9;51(40):7813-5. doi: 10.1021/bi301010z. Epub 2012 Sep 28.
8
Protein activity regulation by conformational entropy.构象熵对蛋白质活性的调节。
Nature. 2012 Aug 9;488(7410):236-40. doi: 10.1038/nature11271.
9
Extreme entropy-enthalpy compensation in a drug-resistant variant of HIV-1 protease.HIV-1 蛋白酶耐药变异体中的极端熵-焓补偿。
ACS Chem Biol. 2012 Sep 21;7(9):1536-46. doi: 10.1021/cb300191k. Epub 2012 Jul 2.
10
Hydrophobic core flexibility modulates enzyme activity in HIV-1 protease.疏水性核心的柔韧性调节 HIV-1 蛋白酶的酶活性。
J Am Chem Soc. 2012 Mar 7;134(9):4163-8. doi: 10.1021/ja2095766. Epub 2012 Feb 28.